This work evaluates the ability of two genes, IGFBP3 and F3, as analyzed in FFPE core needle biopsy tissue, to provide prognostic information about the expected survival time of a prostate cancer patient when combined with currently used clinical parameters. Here, IGFBP3 is linked to prostate cancer.